Pancreatic cancer: A model cancer for the study of the therapeutic effects of anticoagulants

doi:10.4251/wjgo.v1.i1.38

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 1, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3966)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

367

HTML

2338

Figures (1-1)

626

Tables (1-1)

635

Sum=3966

Oct 15, 2009 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Guidelines For Clinical Practice

World J Gastrointest Oncol. Oct 15, 2009; 1(1): 38-40
Published online Oct 15, 2009. doi: 10.4251/wjgo.v1.i1.38

Open in New Tab Full Size Figure Download Figure

Figure 1 Early death burden (EDB) of patients with APC (advanced pancreatic cancer) compared to patients with mCRC (metastatic colorectal cancer). The key lists the trials reviewed and the figures (%) for 3-mo survival. Detailed data can be found in reference 7.

Citation: Maraveyas A. Pancreatic cancer: A model cancer for the study of the therapeutic effects of anticoagulants. World J Gastrointest Oncol 2009; 1(1): 38-40
URL: https://www.wjgnet.com/1948-5204/full/v1/i1/38.htm
DOI: https://dx.doi.org/10.4251/wjgo.v1.i1.38